What Cancer Study Group does

Cancer Study Group, operating as CancerNavigator, is a Washington, DC-based healthcare services company founded in 2019 that provides cancer patient navigation support through employer and union health plans. The company's core product, CancerNavigator, delivers 1:1 dedicated support from Oncology Certified Nurses who guide cancer patients—particularly those recently diagnosed—to appropriate in-network treatment centers best equipped for their specific cancer type and stage. The service addresses a documented problem that 40% of cancer patients fail to reach well-equipped experts for their condition, resulting in higher risk of poor outcomes. The offering consists of two components: direct nurse-led patient support and deep navigation research providing custom education on cancer types and identification of optimal care centers.

The business operates on a B2B2C subscription model, distributing exclusively through self-insured employers and labor unions that embed the service as a health benefit for their members and employees. The company serves 50+ union health plans and employers nationally, with sales motion focused on direct outreach to HR benefits managers and union health plan administrators. The technology footprint is minimal: the company explicitly positions itself as a human-expert service rather than a technology platform, with no app, no search tool, and no disclosed AI capabilities. A "Navigation Database" is referenced as a supporting product capability for research and center identification.

Cancer Study Group is a privately held for-profit company with 11-50 employees, co-founded by Adam Bradley and Spencer Bradley. No funding rounds, revenue figures, or financial details are publicly disclosed. The company's value proposition rests on clinical talent (certified oncology nursing staff) and embedded distribution through union and employer health plans, rather than proprietary technology or data assets.

Name

Cancer Study Group

Legal name

Cancer Study Group

Website

https://cancerstudygroup.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

11–50 employees

Short description

Cancer Study Group (DBA CancerNavigator) provides 1:1 cancer patient navigation support through Oncology Certified Nurses, delivered via employer and union health plans to help cancer patients reach appropriate in-network treatment centers.

Ownership category

akta.pro rank

Product category

Healthcare Patient Navigation Services

NAICS

Ambulatory Health Care Services (621)

SIC

Services-Health Services (8000)

akta.pro primary industry

Oncology Remote Symptom Monitoring & Care Navigation (HLALAFAD)

akta.pro secondary industry

Oncology Telemedicine Platforms (HLALAGAH)

Keywords

• Cancer care navigation
• Oncology nurse support
• Employer health benefits
• Patient navigation services
• Union health plans

Headquarters

HQ city

Washington

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Health Plan Support Services: CancerNavigator is a support service offered through employer and union health plans. The revenue model appears to be B2B subscription-based, where employers and unions pay for cancer navigation services as part of their health benefit offerings to members/employees.

Go-to-market motion1 record

Distribution channels1 record

Core offering

CancerNavigator is a cancer patient navigation support service sold through employer and union health plans. Oncology Certified Nurses work 1:1 with members to provide compassionate guidance, custom education on specific cancer types, and identification of in-network treatment centers best equipped for each member's care. The service is delivered as a human-led offering with no app or search tool involved.

Product overview

CancerNavigator is a single, unified patient support service designed to help cancer patients navigate their care journey. The service consists of two main components: 1:1 Dedicated Support, where Oncology Certified Nurses work directly with patients, and Deep Navigation Research, which provides custom education and guidance on specific cancer types and identifies the best-equipped in-network treatment centers. The product is delivered exclusively through employer and union health plans, serving 50+ union health plans and employers across the country.

Differentiator

Problem solved

Functional benefit

Products and services

• CancerNavigator A cancer patient navigation support service offered exclusively through employer and union health plans, in which Oncology Certified Nurses provide 1:1 dedicated guidance to members and conduct Deep Navigation Research to deliver custom education on the member's specific cancer type and identify in-network treatment centers best equipped for their care. Designed for self-insured employers, labor unions, and their members/employees, with no app or search tool involved.

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators1 record

Recent moves4 records

Expansion highlights4 records

Direct peers

• Rightway Healthcare: Employer-focused healthcare navigation platform combining care guidance and pharmacy benefits; competes for the same self-insured employer buyer and uses human-plus-tech delivery similar to CancerNavigator's model.
• Accolade: Public benefits-navigation platform offering personalized healthcare guidance to employees of large self-insured employers; overlaps directly with CancerNavigator's B2B employer health plan channel and core navigation function.
• Health Advocate: Subsidiary of TELUS Health offering employee health advocacy, navigation, and clinical support services to employers and unions; a long-standing competitor in the employer health plan navigation category.
• Included Health: Virtual care and navigation company serving employers and health plans, with dedicated oncology and complex care navigation offerings; directly comparable employer-channel GTM and cancer focus.
• Quantum Health: Healthcare navigation and care coordination firm sold to self-insured employers; competes for the same HR/benefits buyer and addresses complex-condition member support similar to CancerNavigator.

Emerging players

• Carrot Fertility: Specialty benefit navigation provider for fertility care, sold through employer health plans; comparable specialty-navigation-for-employers playbook and pricing model, though in a different clinical condition.
• Progyny: Employer-sponsored fertility benefits and care navigation company; analogous specialty-condition navigation model delivered through employer benefits, with a clinical-expert-led differentiation similar to CancerNavigator's oncology nurses.

Others

• WiserTogether: Healthcare decision-support and navigation tools for employers and health plans; an adjacent enabling technology provider that historically competed in the employer navigation category.
• Novartis Patient Navigator / Pfizer RxPathways: Pharma-sponsored patient navigation and access programs for oncology patients; comparable clinical-navigation services targeting cancer patients, though funded by manufacturers rather than employer/union buyers.

Broad incumbents

• eviCore (Evernorth): Part of Cigna's Evernorth, providing utilization management and care navigation for complex treatments including oncology; a large incumbent offering payer- and employer-facing cancer navigation services.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cancer Study Group